Ocular Therapeutix Inc. (OCUL)
Ocular Therapeutix Statistics
Share Statistics
Ocular Therapeutix has 159.3M shares outstanding. The number of shares has increased by 2.67% in one year.
| 159.3M |
| 2.67% |
| 1.15% |
| 80.15% |
| n/a |
| 41 |
| n/a |
Short Selling Information
The latest short interest is 13.83M, so 8.68% of the outstanding shares have been sold short.
| 13.83M |
| 8.68% |
| 8.72% |
| 7.67 |
Valuation Ratios
The PE ratio is -6.98 and the forward PE ratio is -6.07. Ocular Therapeutix's PEG ratio is -0.59.
| -6.98 |
| -6.07 |
| 21.21 |
| 2 |
| 4.29 |
| -9.94 |
| -0.59 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Ocular Therapeutix.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 10.66, with a Debt / Equity ratio of 0.24.
| 10.66 |
| 10.59 |
| 0.24 |
| -0.43 |
| -0.56 |
| -12.65 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $232,565.69 |
| $-706,226.28 |
| 274 |
| 0.14 |
| 1.85 |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by 82.79% in the last 52 weeks. The beta is 1.41, so Ocular Therapeutix's price volatility has been higher than the market average.
| 1.41 |
| 82.79% |
| 7.51 |
| 8.46 |
| 67.26 |
| 1,750,338 |
Income Statement
In the last 12 months, Ocular Therapeutix had revenue of 63.72M and earned -193.51M in profits. Earnings per share was -1.22.
| 63.72M |
| 58.1M |
| -171.78M |
| -193.51M |
| -176.14M |
| -179.93M |
| -1.22 |
Balance Sheet
The company has 392.1M in cash and 75.78M in debt, giving a net cash position of 316.32M.
| 392.1M |
| 75.78M |
| 316.32M |
| -891.08M |
| 405.92M |
| 349.77M |
Cash Flow
In the last 12 months, operating cash flow was -134.68M and capital expenditures -1.29M, giving a free cash flow of -135.97M.
| -134.68M |
| -1.29M |
| -135.97M |
| -0.86 |
Margins
Gross margin is 91.17%, with operating and profit margins of -269.57% and -303.67%.
| 91.17% |
| -269.57% |
| -303.67% |
| -303.67% |
| -276.42% |
| -269.57% |
| -213.37% |
Dividends & Yields
OCUL does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for OCUL is $15, which is 66.1% higher than the current price. The consensus rating is "Buy".
| $15 |
| 66.1% |
| Buy |
| 9 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 1.93 |
| 1 |